GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Wiley  (267)
  • Chen, Yan  (267)
  • 1
    In: The Laryngoscope, Wiley, Vol. 125, No. 9 ( 2015-09), p. 2113-2118
    Abstract: To further recognize the comorbid diseases of immunoglobulin G4‐related sialadenitis (IgG4‐RS) in the head and neck region and to observe the response of these conditions to immunomodulatory therapy. Study Design Retrospective review. Methods The symptoms of comorbid diseases and medical histories in 51 patients (24 men, 27 women; median age, 55 years) diagnosed with IgG4‐RS were analyzed. Thirty‐six patients received immunomodulatory therapy and were followed up for 10.4 ± 5.9 months. Computed tomography (CT) examination was performed before and after therapy. Results Rhinosinusitis occurred in 58.8% patients, and manifested with the symptoms of nasal obstruction, nasal xerosis, and hyposmia. In addition, 43.1% patients had allergic rhinitis. Lymphadenopathy was identified in 74.5% patients. Lacrimal gland swelling occurred in 78.4% patients. Extraocular muscles, otologic organs, skin and superficial soft tissue, and cranial nerves were also involved. All of the lesions were relieved after immunomodulatory therapy. The Lund‐Mackay scores decreased (9.6 ± 5.6 to 1.0 ± 2.2) according to CT analyses ( P   〈  .05). Mean CT volumes of the swollen lymph nodes and lacrimal glands decreased from 1.21 ± 0.61 cm 3 to 0.59 ± 0.35 cm 3 and from 2.25 ± 1.35 cm 3 to 0.70 ± 0.32 cm 3 , respectively ( P 〈 .05) after treatment. Conclusions IgG4‐RS could potentially develop with involvement of ocular adnexa, sinonasal cavities, ears, lymph nodes, skin and superficial soft tissue, and cranial nerves in the head and neck region. Immunomodulatory therapy could be effective in controlling both the comorbid diseases of IgG4‐RS and sialadenitis of the major salivary glands. Level of Evidence 4 Laryngoscope , 125:2113–2118, 2015
    Type of Medium: Online Resource
    ISSN: 0023-852X , 1531-4995
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2015
    detail.hit.zdb_id: 2026089-1
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Journal of Digestive Diseases, Wiley, Vol. 21, No. 1 ( 2020-01), p. 46-51
    Abstract: The prevalence of inflammatory bowel disease (IBD) has been increasing worldwide, and the risk of infection has increased due to the use of immunosuppressive and biologic medications. Some of these infections can be prevented with vaccinations. The aim of this study was to evaluate the vaccination practices of Chinese gastroenterologists for patients with IBD. Methods Questionnaires based on quick response codes were sent using email and the WeChat platform to gastroenterologists at 20 hospitals in China. The vaccination practices of the gastroenterologists, including vaccinating for hepatitis B, hepatitis A, and varicella, were assessed. Results Of the 468 gastroenterologists who received the questionnaire, 307 (65.6%) completed it. Of the gastroenterologists who were most concerned about hepatitis B; 83.4% always or frequently asked about an infection history, 53.7% took an immunization history, and 73.6% tested patients for hepatitis B infection. However, few gastroenterologists did so for hepatitis A or varicella. The proportion of patients who were asked about an infection and immunization history and tested for varicella infection was 16.0%, 15.0%, and 9.4%, respectively. Only a few gastroenterologists recommended vaccination for patients without an infection before IBD medical treatment (26.7% for hepatitis A, 45.6% for hepatitis B, and 28% for varicella vaccination). Conclusion Vaccination practices for patients with IBD used by Chinese gastroenterologists vary greatly, suggesting that education about immunization is needed.
    Type of Medium: Online Resource
    ISSN: 1751-2972 , 1751-2980
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2020
    detail.hit.zdb_id: 2317117-0
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    In: Medical Physics, Wiley, Vol. 49, No. 10 ( 2022-10), p. 6728-6738
    Abstract: Ultra‐high dose rate FLASH irradiation (FLASH‐IR) has been shown to cause less normal tissue damage compared with conventional irradiation (CONV‐IR), this is known as the “FLASH effect.” It has attracted immense research interest because its underlying mechanism is scarcely known. The purpose of this study was to determine whether FLASH‐IR and CONV‐IR induce differential inflammatory cytokine expression using a modified clinical linac. Materials and methods An Elekta Synergy linac was used to deliver 6 MeV CONV‐IR and modified to deliver FLASH‐IR. Female FvB mice were randomly assigned to three different groups: a non‐irradiated control, CONV‐IR, or FLASH‐IR. The FLASH‐IR beam was produced by single pulses repeated manually with a 20‐s interval (Strategy 1), or single‐trigger multiple pulses with a 10 ms interval (Strategy 2). Mice were immobilized in the prone position in a custom‐designed applicator with Gafchromic films positioned under the body. The prescribed doses for the mice were 6 to 18 Gy and verified using Gafchromic films. Cytokine expression of three pro‐inflammatory cytokines (tumor necrosis factor‐α [TNF‐α], interferon‐γ [IFN‐γ] , interleukin‐6 [IL‐6]) and one anti‐inflammatory cytokine (IL‐10) in serum samples and skin tissue were examined within 1 month post‐IR. Results The modified linac delivered radiation at an intra‐pulse dose rate of around 1 × 10 6 Gy/s and a dose per pulse over 2 Gy at a source‐to‐surface distance (SSD) of 13 to 15 cm. The achieved dose coverage was 90%–105% of the maximum dose within −20 to 20 mm in the X direction and 95% within −30 to 30 mm in the Y direction. The absolute deviations between the prescribed dose and the actual dose were 2.21%, 6.04%, 2.09%, and 2.73% for 6, 9, 12, and 15 Gy as measured by EBT3 films, respectively; and 4.00%, 4.49%, and 2.30% for 10, 14, and 18 Gy as measured by the EBT XD films, respectively. The reductions in the CONV‐IR versus the FLASH‐IR group were 4.89%, 10.28%, −7.8%, and −22.17% for TNF‐α, IFN‐γ, IL‐6, and IL‐10 in the serum on D6, respectively; 37.26%, 67.16%, 56.68%, and −18.95% in the serum on D31, respectively; and 62.67%, 35.65%, 37.75%, and −12.20% for TNF‐α, IFN‐γ, IL‐6, and IL‐10 in the skin tissue, respectively. Conclusions Ultra‐high dose rate electron FLASH caused lower pro‐inflammatory cytokine levels in serum and skin tissue which might mediate differential tissue damage between FLASH‐IR and CONV‐IR.
    Type of Medium: Online Resource
    ISSN: 0094-2405 , 2473-4209
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2022
    detail.hit.zdb_id: 1466421-5
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    In: Lipids, Wiley, Vol. 44, No. 8 ( 2009-08), p. 719-723
    Abstract: Recently, two polymorphisms (rs1884052 and rs3778099) of estrogen receptor α (ER‐alpha) gene were identified as being associated with primary quantitative bone mineral density (BMD) in a genome‐wide association (GWA) study in Framingham cohorts. In this study we aimed at investigating the association of rs1884052 and rs3778099, and another polymorphism (rs2234693) located at intron 1 of the ER‐alpha gene with BMD, body mass index (BMI), glucose, triglyceride, and total cholesterol (CHO) levels in Chinese Hans. We recruited 425 consecutive adult volunteers who had a physical examination in the Jinan Maternity and Child Care Hospital. We did not observe significant association of rs1884052 and rs3778099 with BMD, BMI, glucose, triglyceride, and total cholesterol (CHO) levels. For rs2234693, increased levels of BMD for hip, spine or whole‐body regions were consistently observed in TT/TC genotype carriers than in CC genotype carriers, although the board line significance diminished after adjusting for age and gender. However, significant association of rs2234693 with glucose and CHO levels were observed in our sample. Subjects with TC/CC genotypes were associated with an increased level of glucose ( p = 0.013) and CHO ( p = 0.032) levels than subjects with TT genotypes. In conclusion, we did not confirm the association of rs1884052 and rs3778099 with BMD originally discovered in a GWA study; however, we made novel discoveries that rs2234693 was associated with glucose and CHO levels in Chinese Hans.
    Type of Medium: Online Resource
    ISSN: 0024-4201 , 1558-9307
    Language: English
    Publisher: Wiley
    Publication Date: 2009
    detail.hit.zdb_id: 2030265-4
    SSG: 12
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 5
    In: Acta Paediatrica, Wiley, Vol. 101, No. 6 ( 2012-06), p. 583-586
    Type of Medium: Online Resource
    ISSN: 0803-5253
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2012
    detail.hit.zdb_id: 1492629-5
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 6
    In: Cell Proliferation, Wiley, Vol. 50, No. 1 ( 2017-02)
    Abstract: Induced pluripotent stem cell ( iPSC )‐derived cardiomyocytes are a promising source of cells for regenerative heart disease therapies, but progress towards their use has been limited by their low differentiation efficiency and high cellular heterogeneity. Previous studies have demonstrated expression of adrenergic receptors ( AR s) in stem cells after differentiation; however, roles of AR s in fate specification of stem cells, particularly in cardiomyocyte differentiation and development, have not been characterized. Materials and methods Murine‐induced pluripotent stem cells (mi PSC s) were cultured in hanging drops to form embryoid bodies, cells of which were then differentiated into cardiomyocytes. To determine whether AR s regulated mi PSC differentiation into cardiac lineages, effects of the AR agonist, epinephrine ( EPI ), on mi PSC differentiation and underlying signalling mechanisms, were evaluated. Results Treatment with EPI , robustly enhanced mi PSC cardiac differentiation, as indicated by increased expression levels of cardiac‐specific markers, GATA 4 , Nkx2.5 and Tnnt2 . Although β‐ AR signalling is the foremost signalling pathway in cardiomyocytes, EPI ‐enhanced cardiac differentiation depended more on α‐ AR signalling than β‐ AR signalling. In addition, selective activation of α 1 ‐ AR signalling with specific agonists induced vigorous cardiomyocyte differentiation, whereas selective activation of α 2 ‐ or β‐ AR signalling induced no or less differentiation, respectively. EPI ‐ and α 1 ‐ AR ‐dependent cardiomyocyte differentiation from mi PSC s occurred through specific promotion of CPC proliferation via the MEK ‐ ERK 1/2 pathway and regulation of mi PS cell‐cycle progression. Conclusions These results demonstrate that activation of AR s, particularly of α 1 ‐ AR s, promoted mi PSC differentiation into cardiac lineages via MEK ‐ ERK 1/2 signalling .
    Type of Medium: Online Resource
    ISSN: 0960-7722 , 1365-2184
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2017
    detail.hit.zdb_id: 2019986-7
    SSG: 12
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 7
    In: Phytotherapy Research, Wiley, Vol. 35, No. 8 ( 2021-08), p. 4511-4525
    Abstract: Erianin is a small‐molecule compound that is isolated from Dendrobium chrysotoxum Lindl . In recent years, it has been found to have evident antitumor activity in various cancers, such as bladder cancer, cervical cancer, and nasopharyngeal carcinoma. In this study, we assessed the effect of erianin on lung cancer in terms of cell growth inhibition and the related mechanism. First, erianin at a concentration of less than 1 nmol/L exhibited cytotoxicity in H1975, A549, LLC lung cancer cells, did not cause marked growth inhibition in normal lung and kidney cells, induced obvious apoptosis and G2/M phase arrest of cells, and inhibited the migration and invasion of lung cancer cells in vitro. Second, in a mouse xenograft model of lewis lung cancer (LLC), oral administration of erianin (50, 35, and 10 mg kg −1  day −1 for 12 days) substantially inhibited nodule growth, reduced the fluorescence counts of lewis cells and the percentage vascularity of tumor tissues, increased the number of apoptotic tumor cells, the thymus indices, up‐regulated the levels of interleukin (IL)‐2 and tumor necrosis factor‐α (TNF‐α), decreased IL‐10 levels and the spleen index, and enhanced immune function. Lastly, the possible targets of erianin were determined by molecular docking and verified via western blot assay. The results indicated that erianin may achieve the above effects via inhibiting the phosphoinositide 3‐kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway in vitro and vivo. Taken together, the results showed that erianin had obvious antitumor effects via inhibiting the PI3K/Akt/mTOR pathway in vitro and vivo and may have potential clinical value for the treatment of lung cancer.
    Type of Medium: Online Resource
    ISSN: 0951-418X , 1099-1573
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2021
    detail.hit.zdb_id: 1493490-5
    SSG: 15,3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 8
    In: Journal of Food Science, Wiley, Vol. 87, No. 5 ( 2022-05), p. 2185-2196
    Abstract: Collagen peptide from Acaudina molpadioides (AMP) showed antioxidative activity in H 2 O 2 ‐induced RAW264.7 cells in our pervious study. In this study, it was observed that AMP could effectively improve the morphology and function of liver in CCl 4 ‐induced mice. After 200 mg/kg AMP treatment, the content of MDA in liver decreased by 62.3%, and the level of antioxidant enzymes (SOD, GSH‐Px, and CAT) increased by more than 65%. Western blot results disclosed that AMP (200 mg/kg) upregulated the Nrf2 level by 73.8% and downregulated Keap1 by 41.0% in CCl 4 ‐induced mice liver. The levels of p‐ERK, p‐JNK, and p‐p38 in 200 mg/kg AMP treatment groups decreased by 57.3%, 40.9%, and 40.6%, but the levels of p‐PI3K and p‐AKT increased by 162.6% and 60.3%, respectively. Furthermore, the trends of Nrf2, Keap1, p‐ERK, p‐JNK, p‐p38, p‐PI3K, and p‐AKT levels in H 2 O 2 ‐induced RAW264.7 cells after AMP treatment were similar to the results in CCl 4 ‐induced mice liver. These findings provided evidence that AMP exerted antioxidant activity via Keap1/Nrf2‐ARE, PI3K/AKT, and MAPKs pathways in vivo and in vitro. Therefore, the collagen peptide from A. molpadioides might represent a novel functional food to prevent acute liver injury via attenuation of oxidative stress.
    Type of Medium: Online Resource
    ISSN: 0022-1147 , 1750-3841
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2022
    detail.hit.zdb_id: 2006705-7
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 9
    In: Clinical and Translational Medicine, Wiley, Vol. 11, No. 11 ( 2021-11)
    Type of Medium: Online Resource
    ISSN: 2001-1326 , 2001-1326
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2021
    detail.hit.zdb_id: 2697013-2
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 10
    In: CNS Neuroscience & Therapeutics, Wiley, Vol. 29, No. 12 ( 2023-12), p. 4082-4092
    Abstract: Diterpene ginkgolides meglumine injection (DGMI) is a platelet‐activating factor receptor (PAFR) antagonist that can be used to treat acute ischemic stroke (AIS). This study evaluated the efficacy and safety of an intensive antiplatelet strategy based on PAFR antagonists and explored the underlying mechanisms of PAFR antagonists in AIS treatment. Methods This is a retrospective study applying propensity score methods to match AIS patients treated with DGMI to nontreated patients. The primary outcome was functional independence (modified Rankin Scale [mRS] 0–2) at 90 days. The safety outcome was bleeding risk. We used McNemar test to compare the efficacy outcome. Subsequently, the network pharmacology analysis was performed. Results 161 AIS patients treated with DGMI in the study were matched with 161 untreated patients. Compared with untreated patients, DGMI‐treated patients had a significantly higher rate of mRS ranking 0–2 at 90 days (82.0% vs. 75.8%, p 〈 0.001), without increased risk of bleeding. The gene enrichment analysis showed that the overlap genes of DGMI targeted and AIS‐related enriched in thrombosis and inflammatory‐related signaling pathways. Conclusions An intensive antiplatelet strategy of DGMI plus traditional antiplatelet agents is effective in treating AIS and may work by mediating post‐stroke inflammation and thrombosis.
    Type of Medium: Online Resource
    ISSN: 1755-5930 , 1755-5949
    Language: English
    Publisher: Wiley
    Publication Date: 2023
    detail.hit.zdb_id: 2423467-9
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...